PerpEquities

Equity · Healthcare

Is Cigna (CI) tradable as a perp? Not yet

Cigna Group provides health insurance and related services in the US, operating through Evernorth (pharmacy, care solutions) and Cigna Healthcare (medical, dental, Medicare plans).

Not yet listed on any perp exchange

No perpetual-futures venue lists CI yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
TAKEDAELVMRNACAHBSXREGN

Price chart

Interactive TradingView chart

TradingView symbol NYSE:CI

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-11-05 · next report 2027-02-04 · Updated 37m ago
All financials →

Valuation & key figures

Market cap
$79.7B
Updated 37m ago
Revenue
$286.3B
Trailing 12 months
Revenue growth
+5%
Next fiscal year
Profit margin
+2.1%
P/E
13.3
Peer P/E 19.6
P/S
0.3
Peer P/E
19.6
Similar listed perps
Free cash flow
$8.3B
Trailing 12 months
Net income
$6B
Trailing 12 months
Revenue estimate
$287.4B
Next fiscal year
Earnings
2027-02-04
Revenue est. $74.9B · Updated 37m ago
Dividend
$1.56
2026-12-03
Revenue (TTM)$286B+6.8% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)3.3%-0.1 pp vs a year agoOperating income $9.58B
Net income (TTM)$5.99B-2.6% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$8.27B+11.1% vs a year agoCapex $1.16B
Diluted EPS (TTM)$22.660.0% vs a year agoSum of the last 4 quarters
Net cash-$25B+8.0% vs a year agoCash + short-term investments - debt
  • Last report (2026-11-05): revenue beat by 1.4%, EPS beat by 6.1%Revenue $73.7B vs $72.6B expected (+1.4%); EPS $7.98 vs $7.52 (+6.1%).
  • Revenue growth slowing: 5.6% year on yearQ3 '26 revenue $73.7B, against an average of 7.8% over the four quarters before.
  • Operating margin 3.3% (TTM), -0.1 pp on a year agoOperating income grew 4.6% while revenue grew 6.8%.
  • 16.0% of pre-tax profit is eaten by non-operating lossesPre-tax income $8.26B vs operating income $9.58B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Evernorth$63.8B+5.6%84.5%
Cigna Healthcare$11.7B+7.1%15.5%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 263 lines Cigna Corporation reported to the SEC

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202630.51$287.4B+5%15
FY 202733.49$299.7B+9%15
FY 202837.14$316B+15%11
FY 202941.33$335.6B+22%4
FY 203046.63$347.8B+26%4
Q1 20278.33$71.5B+4%18

Company events

6
2027-02-04EarningsActual - / Estimate 7.41-
2026-12-03Dividend$1.56-
2026-11-05Earnings · Before market openActual 7.98 / Estimate 7.52Beat
2026-09-08Dividend$1.56-
2026-07-30EarningsActual 7.78 / Estimate 7.6Beat
2026-06-04Dividend$1.56-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
TAKEDA$67.5B2.327.2+8.2%1ELV$95.4B0.518.7+2.5%2MRNA$96.4B43.3-30.3-141.4%23CAH$62B0.234.5+0.7%1BSX$60.8B2.917.7+16.6%3REGN$99B5.920.5+28.5%7HCA$102.5B1.357.5+8.6%2CVS$104B0.29.4+2.6%3

Analyst track record

How the analysts covering CI have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings109332
Analysts2534
Buy / hold / sell86 / 23 / 0253 / 79 / 0
Upgrades / downgrades / initiations1 / 3 / 18 / 5 / 7
Price targets hit / missed7 / 95 (7%)10 / 300 (3%)
Avg. return after a rating (TipRanks)-10.9%-16.3%
Best / worst call+4.0% / -24.6%+4.0% / -48.5%

After buy calls on this stock: median 21-day move +1.8% vs S&P 500 +0.1% (n = 256)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Ann HynesMizuho Securities22% hit rate on this stock · 9 targets measuredBuytarget $340Jun 8, 2026
  2. David S MacdonaldTruist Financial19% hit rate on this stock · 16 targets measuredBuytarget $350Oct 2, 2026
  3. Andrew Mok CFABarclays17% hit rate on this stock · 12 targets measuredHoldtarget $310Oct 1, 2026

Latest ratings

DateAnalystCallTarget
Nov 5, 2026Kevin FischbeckBank of America SecuritiesBuyMaintained$378article ↗
Nov 5, 2026Elizabeth Anderson CFAEvercore ISIHoldMaintained$290article ↗
Nov 5, 2026Kevin FischbeckBank of America SecuritiesBuyMaintained$378
Nov 4, 2026Lance WilkesBernsteinBuyMaintained$387article ↗
Oct 23, 2026Jessica TassanPiper SandlerBuyMaintained$370article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$280$300$320$340Dec 25 · Buy 18 · Hold 3 · Sell 0Dec 25Jan 26 · Buy 17 · Hold 3 · Sell 0Feb 26 · Buy 17 · Hold 2 · Sell 0Feb 26Mar 26 · Buy 18 · Hold 1 · Sell 0Apr 26 · Buy 17 · Hold 1 · Sell 0Apr 26May 26 · Buy 16 · Hold 3 · Sell 0Jun 26 · Buy 16 · Hold 3 · Sell 0Jun 26Jul 26 · Buy 18 · Hold 3 · Sell 0Aug 26 · Buy 17 · Hold 4 · Sell 0Aug 26Sep 26 · Buy 17 · Hold 5 · Sell 0Oct 26 · Buy 17 · Hold 6 · Sell 0Oct 26Nov 26 · Buy 17 · Hold 6 · Sell 0Dec 25 · avg. target $340Jan 26 · avg. target $341Feb 26 · avg. target $340Mar 26 · avg. target $343Apr 26 · avg. target $340May 26 · avg. target $345Jun 26 · avg. target $345Jul 26 · avg. target $350Aug 26 · avg. target $346Sep 26 · avg. target $343Oct 26 · avg. target $343Nov 26 · avg. target $343Dec 25 · month-end close $275Jan 26 · month-end close $274Feb 26 · month-end close $290Mar 26 · month-end close $267Apr 26 · month-end close $291May 26 · month-end close $277Jun 26 · month-end close $276Jul 26 · month-end close $279Aug 26 · month-end close $276Sep 26 · month-end close $272Oct 26 · month-end close $298Nov 26 · month-end close $298

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 6, 2026 · 109 ratings